Dopamine-N-methyl-D-aspartate interactions in the modulation of locomotor activity and memory consolidation in mice

European Journal of Pharmacology

Volumn 308, Issue 1, 1996, Pages 1-12

  Mele, Andrea ^a   Castellano, Claudio ^b   Felici, Andrea ^a   Cabib, Simona ^b   Caccia, Silvio ^c   Oliverio, Alberto ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Inst di Psicobiologia e P   (Italy)

^c MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

Dopamine; Locomotor activity; Memory; Mouse; Neuroleptic, chronic; NMDA receptor antagonist

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 3 METHYL 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DIZOCILPINE; DOPAMINE; HALOPERIDOL; N METHYL DEXTRO ASPARTIC ACID; QUINPIROLE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DRUG EFFECT; DRUG RECEPTOR BINDING; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; MEMORY; MOUSE; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; SCHIZOPHRENIA;

EID: 0030579849     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(96)00266-X     Document Type: Article

References (52)

1. 2 receptor antagonists differently affect cocaine-induced locomotor hyperactivity in the mouse, Psychopharmacology 105, 335.
2. Calabresi P., A. Pisani, N.B. Mercuri and G. Bernardi, 1996, The corticostriatal projection: from synaptic plasticity to dysfunctions of the basal ganglia, Trends Neurosci. 19, 19.
3. Carlsson M.L., 1993. Are the disparate pharmacological profiles of competitive and un-competitive NMDA receptor antagonists due to different baseline activities of distinct glutamatergic pathways? [Hypothesis], J. Neural Transm. 94, 1.
4. Carlsson, M.L. and A. Carlsson, 1989, The NMDA receptor antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice, J. Neural Transm. 75, 221.
5. Carlsson, M.L. and A. Carlsson, 1990, Interactions between glutamatergic and monoaminergic systems within the basal ganglia - implications for schizophrenia and Parkinson's disease, Trends Neurosci. 13, 276.
6. 2 receptors, Behav. Neural Biol. 56, 283.
7. Cestari, V., C. Castellano, S. Cabib and S. Puglisi-Allegra, 1992,. Strain-dependent effects of post-training dopamine receptor agonists and antagonists on memory storage in mice, Behav. Neural Biol. 58, 58.
8. Cestari, V., A, Mele, A. Oliverio and C. Castellano, 1996, Amygdala lesions block the effect of cocaine on memory in mice, Brain Res., in press.
9. Creese, I. and A. Chen, 1985, Selective D-1 dopamine receptor increase following chronic treatment with SCH 23390, Eur. J. Pharmacol. 109, 127.
10. Dall'Olio, R., O. Gandolfi and N. Montanaro, 1992, Effect of chronic treatment with dizocilpine (MK-801) on the behavioral response to dopamine receptor agonists in the rat, Psychopharmacology 107, 591.
11. DeNoble, V.J., K.W. Jones, C.L. Schaeffer and L.M. Bauerle, 1990, 3-((±)-Carboxypiperazin-4-yl)propyl-1-phosphonic acid (CPP) and phencyclidine produce a deficit of passive avoidance retention in rats, Eur. J. Pharmacol. 175, 197.
12. Fontana, D.J., R.M. Post and A. Pert, 1993. Conditioned increases in mesolimbic dopamine overflow by stimuli associated with cocaine, Brain Res. 629, 31.
13. Grace, A.A., 1991, Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia, Neuroscience 41, 1.
14. 1 dopamine receptor up-regulation, J. Pharmacol. Exp. Ther. 238, 846.
15. Imperato, A., M.G. Scrocco, S. Bacchi and L. Angelucci, 1990, NMDA receptors and in vivo release in the nucleus accumbens and caudatus, Eur. J. Pharmacol. 187, 555.
16. Javitt, D.C. and S.R. Zukin, 1991, Recent advances in the phencyclidine model of schizophrenia. Am. J. Psychiatry 148, 1301.
17. Kashihara, K., T. Hamamura, K, Okumura and S. Otsuki, 1990, Effect of MK-801 on endogenous dopamine release in vivo. Brain Res. 528. 80.
18. Kim, J.S., H.H. Kornhuber, W. Schmid-Burgk and B. Holzmüller, 1980, Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia, Neurosci. Lett. 20, 379.
19. Kiss, J., E. Toth, A. Lajtha and E.S. Vizi, 1994, NMDA receptors are not involved in the MK-801-induced increase of striatal dopamine release in rat: a microdialysis study, Brain Res. 641, 145.
20. 3H]MK-801 binding sites in post-mortem brain regions of schizophrenic patients, J. Neural Transm. 77, 231.
21. 2 receptor modulation in rat striatum and nucleus accumbens after subchronic and chronic haloperidol treatment, Brain Res. 575, 47.
22. Liljequist, S., 1991, Genetic differences in the effects of competitive and non-competitive NMDA receptor antagonists on locomotor activity in mice, Psychopharmacology 104, 17.
23. Lindefors, N., U. Tossman and U. Ungerstedt, 1987. Subchronic haloperidol and sulpiride treatment induced region-specific changes in tissue levels of putative amino acid transmitters in rat brain, Neurosci. Lett. 74, 90.
24. Maldonado-Irizarry, C.S. and A.E. Kelley, 1994, Differential behavioral effects following microinjection of an NMDA receptor antagonist into nucleus accumbens subregions, Psychopharmacology 116, 65.
25. Martin, P., A. Svensson, A. Carlsson and M. Carlsson, 1994, On the roles of dopamine D-1 vs. D-2 receptors for the hyperactivity response elicited by MK-801, J. Neural Transm. 95, 113.
26. Maura, G., R. Carbone and M. Raiteri, 1989, Aspartate-releasing nerve terminals in rat striatum possess D2 dopamine receptors mediating inhibition of release, J. Pharmacol. Exp. Ther. 251, 1142.
27. McGaugh, J.L. and P.W. Landfield, 1970, Delayed development of amnesia following electro-convulsive shock, Physiol. Behav. 5, 1109.
28. 2 dopamine agonist in the one-trial inhibitory avoidance, Psychopharmacology 121, 401.
29. Mele, A., C. Castellano, V. Cestari and A. Oliverio, 1995b, Interaction between the NMDA competitive antagonist CPP and the dopaminergic system in one-trial inhibitory avoidance in C57BL/6 mice, Neurobiol. Learn. Mem. 63, 143.
30. Mondadori, C. and L. Weiskrantz, 1993, NMDA receptor blockers facilitate and impair learning via different mechanisms, Behav. Neural Biol. 60, 205.
31. Mondadori, C., L. Weiskrantz, H. Buerki, F. Petschke and G.E. Fagg, 1989, NMDA receptor antagonists can enhance or impair learning performance, Exp. Brain Res. 75, 449.
32. Morris, R.G.M., E. Anderson, G.S. Lynch and M. Bury, 1986, Selective impairment of learning and blockade of long term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5, Nature 319, 774.
33. Nestler E.J., S.I. Walaas and P. Greengard, 1984, Neuronal phosphoproteins: physiological and clinical implications, Science 225, 1357.
34. 2 receptor blockade on MK-801-induced hyperloccmotion in rats, Psychopharmacology 111, 427.
35. Ouagazzal, A., A. Nieoullon and M. Amalric, 1994, Locomotion activation induced by MK-801 in the rat: postsynaptic interactions with dopamine receptors in the ventral striatum, Eur. J. Pharmacol. 251, 229.
36. Porter, R.H.P., J.G. Greene, D.S. Higgins and J.T. Greenamyre 1994, Polysynaptic regulation of glutamate receptors and mitochondrial enzyme activities in the basal ganglia of rats with unilateral dopamine depletion, J. Neurosci. 14, 7192.
37. Raffa, R.B., M.E. Ortegòn. D.M. Robisch and G.E. Martin, 1989, In vivo demonstration of the enhancement of MK-801 by L-glutamate, Life Sci. 44, 1593.
38. Rupniak, N.M.J., G. Kilpatrick, M.D. Hall, P. Jenner and C.D. Marsden, 1984. Differential alterations in striatal dopamine receptor sensitivity induced by repeated administration of clinically equivalent doses of haloperidol, sulpiride or clozapine in rat, Psychopharmacolcgy 84, 512.
39. 3H]3-(2-Carboxypiperazin-4-yl)propyl-1-phosphonic acid binding, J. Neurochem. 54, 1926.
40. Schmidt, W.J., 1986, Intrastriatal injection of DL-2-amino-5-phosphonovaleric acid (AP-5) induces sniffing stereotypy that is antagonized by haloperidol and clozapine, Psychopharmacology 90, 123.
41. Svensson, A., E. Pileblad and M. Carlsson, 1991, A comparison between the non-competitive NMDA receptor antagonist dizocilpine (MK801) and the competitive NMDA receptor antagonist D-CPPene wth regard to the dopamine turnover and locomotor-stimulatory properties in mice, J. Neural Transm. 85, 117.
42. Tiedtke, P.I., C. Bischoff and W.J. Schmidt, 1990, MK-801-induced stereotypy and its antagonism by neuroeptic drugs, J. Neural Transm. 81, 173.
43. Uchihashi, Y., H Kuribara, Y. Isa, T. Morita and T. Sato, 1994, The disruptive effects of ketamine on passive avoidance learning in mice: involvement of dopaminergic mechanism, Psychopharmacology 116, 40.
44. Ulas, J., L. Nguyen and C.W. Cotman, 1993, Chronic haloperidol treatment enhances binding to NMDA receptors in rat cortex, NeuroReport 4, 1049.
45. Venable, N. and P.H. Kelly, 1990, Effects of NMDA receptor antagonists on passive avoidance learning and retrieval in rats and mice, Psychopharmacology 100, 215.
46. Vezzani, A., R. Serafini, M.A. Stasi, S. Caccia, I. Conti, R.V. Tridico and R. Samanin, 1989, Kinetics of MK-801 and its effect on quinolinic acid-induced seizures and neurotoxicity in rats. J. Pharmacol. Exp. Ther. 249, 278.
47. Waddington, J.L. and K.M. O'Boyle, 1989. Drugs acting on brain dopamine receptors: a conceptual re-evaluation five years after the first selective D-1 antagonist, Pharmacol. Ther. 43, 1.
48. Willins D.L., S. Narayanan, L.J. Wallace and N.J. Uretsky, 1993, The role of dopamine and AMPA/Kainate receptors in the nucleus accumbens in the hypermotility response to MK-801, Pharmacol. Biochem. Behav. 46, 881.
49. 3H]MK-801 labels a site on the N-methyl-D-aspartate receptor channel complex in rats brain membranes, J. Neurochem. 50, 274.
50. Yamamoto, B.K. and M.A. Cooperman, 1994, Differential effects of antipsychotic drug treatment on extracellular glutamate and dopamine concentrations, J. Neurosci. 14, 4159.
51. Yamamoto, B.K. and S. Davy, 1992, Dopaminergic modulation of glutamate release in striatum as measured by microdialysis, J. Neurochem. 58, 1736.
52. Yang, C.R. and G.J. Mogenson, 1986, Dopamine enhances terminal excitability of hippocampal-accumbens neurons via D2 receptor: role of dopamine in presynaptic inhibition, J. Neurosci. 6, 2473